Advertisement

Sympathetic nervous system activity in the obese hypertensive patient: potential role for central alpha-adrenoreceptor agonists

  • Michael Tuck

Abstract

In most industrialized populations a strong association between blood pressure and body weight has been established. Several large-scale studies in the United States have confirmed the relationship between obesity and hypertension (the Framing-ham Study (Kannel et al. 1967); the Evans Country, Georgia Study (Tyroler et al. 1975); the Community Hypertension Evaluation Clinic (Stamler et al. 1978); Hypertensive Detection and Follow-up Program Cooperative Group (1979)). In the Evans county, Georgia study it was demonstrated prospectively that weight gain can increase blood pressure. Over the six-year period of the study, weight gain was associated with a two-fold possibility of developing hypertension. The converse was also true: subjects who were hypertensive at outset gained more weight. In those who were both obese and hypertensive at the outset, a weight reduction programme averaging 8 kg per patient produced very pronounced decrements in both systolic and diastolic blood pressure over a year. Comparing black and white subjects, it was concluded that obese white hypertensives benefited more than blacks from weight loss.

Keywords

Weight Reduction Sympathetic Nervous System Obese Subject Plasma Renin Activity Sodium Intake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ad Hoc Committee of the New Build and Blood Pressure Study, Build Study (1979). Chicago: Society of Actuaries and Association of Life Insurance Medical Directors of America.Google Scholar
  2. 2.
    Ashley FW Jr, Kannel WB (1974) Relation of weight change to changes in atherogenic traits: The Framingham Study. J Chronic Dis 27:103–114.PubMedCrossRefGoogle Scholar
  3. 3.
    Berchtold P, Berger M, Jörgens V, et al (1981) Cardiovascular risk factors and HDL-cholesterol levels in obesity. Int J Obes 5:1–10.Google Scholar
  4. 4.
    Berchtold P, Jörgens V, Kemmer FW, Berger M (1982) Obesity and hypertension: cardiovascular response to weight reduction. Hypertension 4 (Suppl 3): III 50–III 55.Google Scholar
  5. 5.
    Berglund G, Ljungman S, Hartford M, Wilhelmsen L, Björntorp P (1982) Type of obesity and blood pressure. Hypertension 4:692–696.PubMedGoogle Scholar
  6. 6.
    Boehringer K, Beretta-Piccoli C, Weidmann P, Meier A, Ziegler W (1982) Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal and hypertensive subjects. Hypertension 4:687–702.Google Scholar
  7. 7.
    Chiang BN, Periman LV, Epstein FH (1969) Overweight and hypertension: A review. Circulation 39:403–421.PubMedGoogle Scholar
  8. 8.
    Dahl LK, Silver L, Christie RW (1958) Role of salt in the fall of blood pressure accompanying reduction in obesity. N Engl J Med 258:1186–1188.PubMedCrossRefGoogle Scholar
  9. 9.
    Dahl LK (1972) Salt and hypertension. Am J Clin Nutr 25:231–244.PubMedGoogle Scholar
  10. 10.
    DeLuise M, Blackburn GL, Flier JS (1980) Reduced activity of the red-cell sodium potassium pump in human obesity. N Engl J Med 303:1017–1022.CrossRefGoogle Scholar
  11. 11.
    Dustan HP (1983) Mechanisms of hypertension associated with obesity. Ann Intern Med 98 (Part 2): 860–864.PubMedGoogle Scholar
  12. 12.
    Eliahou HE, Iaina A, Gaon T, Shochat J, Modan M (1981) Body weight reduction necessary to attain normotension in the overweight hypertensive patient. Int J Obes 5 suppl 1:157–163.PubMedGoogle Scholar
  13. 13.
    Fletcher AP (1954) The effect of weight reduction upon the blood pressure of obese hypertensive women. Q J Med 47:331–345.Google Scholar
  14. 14.
    Gillum RF, Taylor HL, Brozek J, Polansky P, Blackburn M (1982) Indices of obesity and blood pressure in young men followed 32 years. J Chronic Dis 35:211–219.PubMedCrossRefGoogle Scholar
  15. 15.
    Gordon T, Kannel WB (1976) Obesity and cardiovascular disease: The Framingham Study. J Clin Endocrinol Metab 5:367–375.CrossRefGoogle Scholar
  16. 16.
    Harlan WR, Oberman A, Mitchell RE, Graybiel A (1973) A 30-year study of blood pressure in a white male cohort. In: Onesti G, Kim KE, Mover JH (eds.) Hypertension: Mechanism and Management. Grune & Stratton: New York: 85–91.Google Scholar
  17. 17.
    Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M (1983) Weight and hypertension. Ann Intern Med 98:855–859.PubMedGoogle Scholar
  18. 18.
    Hiramatsu K, Yamada T, Ichikawa K, Izumiyama T, Nagata H (1981) Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am Geriatr Soc 29:25–30.PubMedGoogle Scholar
  19. 19.
    Hubert HB, Feinleib M, McNamara PM, Castelli WP (1982) Obesity as an independent risk factor for cardiovascular disease in Framingham (Abstract). CVD Epidemiol Newslett 31:39.Google Scholar
  20. 20.
    Hypertensive Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program; reduction in mortality of persons with high blood pressure including mild hypertension. (1979) JAMA 242:2562–2571.CrossRefGoogle Scholar
  21. 21.
    Jung RT, Shetty PS, James WPT (1980) Nutritional effects on thyroid catecholamine metabolism. Clin Sci 58:183–191.PubMedGoogle Scholar
  22. 22.
    Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara PN (1967) The relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann Int Med 67:48–59.PubMedGoogle Scholar
  23. 23.
    Kannel WB, Gordon T (1968) Correlations. In: Kannel WB, Gordon T (eds.) The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington DC: DHEW.Google Scholar
  24. 24.
    Lin MH, Romsos DR, Akera T, Leveille GA (1978) Na+-K+-ATPase enzyme units in skeletal muscle from lean and obese mice. Biochem Biophys Res Commun 80:398–404.PubMedCrossRefGoogle Scholar
  25. 25.
    Lynds BG, Seyler SK, Morgan BM (1980) The relationship between elevated blood pressure and obesity in black children. Am J Public Health 70:171–173.PubMedCrossRefGoogle Scholar
  26. 26.
    Maxwell MH, Waks AU, Schroth PC, Karam M, Dornfeld LP (1982) Error in blood pressure measurement due to incorrect cuff size in obese patients. Lancet ii: 33–36.Google Scholar
  27. 27.
    McCue CM, Miller WW, Mauck HP, Robertson L, Parr EL (1979) Adolescent blood pressure in Richmond, Virginia, schools. Virginia Med 106:210–220.Google Scholar
  28. 28.
    Messerli FH (1982) Cardiovascular effects of obesity and hypertension. Lancet i: 1165–1168.CrossRefGoogle Scholar
  29. 29.
    Mujais SK, Tarazi RC, Dustan HP, Fouad RM, Bravo EL (1982) Hypertension in obese patients: haemodynamic and volume studies. Hypertension 4:84–92.PubMedGoogle Scholar
  30. 30.
    Multiple Risk Factor Intervention Trial Research Group: The multiple risk factor intervention trial (MRFIT); A national study of primary prevention of heart disease. (1976) JAMA 235; 825–828.CrossRefGoogle Scholar
  31. 31.
    Patel YC, Eggen DA, Strong JP (1980) Obesity, smoking and atherosclerosis: a study of interassociations. Atherosclerosis 36:481–490.PubMedCrossRefGoogle Scholar
  32. 32.
    Ramsay LE, Ramsay MH, Hettiarachchi J, Davies DL, Winchester J (1978) Weight reduction in a blood pressure clinic. Br Med J 2:244–245.PubMedCrossRefGoogle Scholar
  33. 33.
    Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, Jones MM, Batson HM (1983) Cardiovascular changes after weight reduction in obesity hypertension. Ann Int Med 98:315–319.PubMedGoogle Scholar
  34. 34.
    Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298:1–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Schacter J, Kuller LH, Perfetti C (1982) Blood pressure during the first two years of life. Am J Epidemiol 116:29–41.Google Scholar
  36. 36.
    Siervogel RM, Roche AF, Chumlea WC, Morris JG, Webb P, Knittle JL (1982) Blood pressure, body composition, and fat tissue cellularity in adults. Hypertension 4:382–386.PubMedGoogle Scholar
  37. 37.
    Sims EAH (1982) Mechanisms of hypertension in the overweight. Hypertension 4 (suppl 3): III 43–III 49.Google Scholar
  38. 38.
    Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L, Maxwell M (1982 a) Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 54:1181–1185.CrossRefGoogle Scholar
  39. 39.
    Sowers JR, Whitfield L, Beck FWJ, et al (1982 b) Role of enhanced sympathetic nervous system activity and reduced Na+-K+-dependent adenosine triphosphatase activity in maintenance of elevated blood pressure in obesity: effects of weight loss. Clin Sci 63:121 s–124 s.Google Scholar
  40. 40.
    Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RM (1978) Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA 240:1607–1610.PubMedCrossRefGoogle Scholar
  41. 41.
    Tuck ML, Sowers J, Dornfeld L, Kledzick G, Maxwell M (1981) The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304:930–933.PubMedCrossRefGoogle Scholar
  42. 42.
    Tuck ML, Sowers JR, Dornfeld L, Whitfield L, Maxwell M (1983) Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol 102:252–257.PubMedGoogle Scholar
  43. 43.
    Tyroler HA, Heyden S, Harnes CG (1975) Weight and hypertension: Evans County studies of blacks and whites. In Paul O (ed.) Epidemiology and Control of Hypertension. Stratton Intercontinental: New York: 177–201.Google Scholar
  44. 44.
    York DA, Bray GA, Yukimura Y (1978) An enzymatic defect in the obese (ob/ob) mouse: Loss of thyroid-induced sodium- and potassium-dependent adenosine triphosphatase. Proc Natl Acad Sci, USA 75:477–481.PubMedCrossRefGoogle Scholar
  45. 45.
    Young JB, Landsberg L (1977) Suppression of sympathetic nevous system during fasting. Science 196:1473–1475.PubMedCrossRefGoogle Scholar
  46. 46.
    Young JB, Landsberg L (1979) Effect of diet and cold exposure on norepinephrine turnover in pancreas and liver. Am J Physiol 236:E524-E533.PubMedGoogle Scholar
  47. 47.
    Young JB, Mullen D, Landsberg L (1978) Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism 27:1711–1714.PubMedCrossRefGoogle Scholar
  48. 48.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effect of treatment on morbidity in hypertension; Results of patients with diastolic blood pressure averaging 115–129 (1967) JAMA 202:116–122.CrossRefGoogle Scholar
  49. 49.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. (1970) JAMA 213:1143–1152.CrossRefGoogle Scholar
  50. 50.
    Veterans Administration Cooperative Study on Antihypertensive Agents: Propranolol in the treatment of essential hypertension (1977) JAMA 237:2303–2310.CrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1984

Authors and Affiliations

  • Michael Tuck
    • 1
  1. 1.Endocrinology and MetabolismVA Medical CenterSepulvedaUSA

Personalised recommendations